Safety, tolerability and efficacy of propiverine long-term treatment
Madersbacher H1, Hessdoerfer E2, Martan A3, Nurkjewicz W4, Bruenjes R5, Shah J6 1. Neurourology Unit, University Hospital of Innsbruck, Austria, 2. Consultant, Urology, Berlin, Germany, 3. Dept. Gynecol., University Prague, Czech Republic, 4. Dept. Urology, Warsaw, Poland, 5. Apogepha Arzneimittel GmbH, Dresden, Germany, 6. Urology and Nephrology, UCLH, London, UK
|
|
Abstract 573
|
|
|
Read By Title
Scientific Non Discussion Abstract Session 19
|
|
|